Development of targeted oncolytic virotherapeutics through translational research

By Liu Ta-Chiang   Hwang Tae-Ho   Bell John C   Kirn David H  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 9, 2008-09 ,pp. : 1381-1391

Informa Healthcare

Access to resources Recommend Favorite

Structural analysis of a designed inhibitor complexed with the hemagglutinin-neuraminidase of Newcastle disease virus

By Ryan Charlotte   Zaitsev Viateslav   Tindal David   Dyason Jeffrey   Thomson Robin   Alymova Irina   Portner Allen   Itzstein Mark   Taylor Garry  

Glycoconjugate Journal, Vol. 23, Iss. 1-2, 2006-02 ,pp. : 135-141

Springer Publishing Company

Access to resources Recommend Favorite

Oncolytic vaccinia virus for the treatment of cancer

By Guse Kilian   Cerullo Vincenzo   Hemminki Akseli  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 595-608

Informa Healthcare

Access to resources Recommend Favorite

α2-3- and α2-6- N-linked sialic acids allow efficient interaction of Newcastle Disease Virus with target cells

By Sánchez-Felipe Lorena   Villar Enrique   Muñoz-Barroso Isabel  

Glycoconjugate Journal, Vol. 29, Iss. 7, 2012-10 ,pp. : 539-549

Springer Publishing Company

Access to resources Recommend Favorite

A Differential Scanning Calorimetric Study of Newcastle Disease Virus: Identification of Proteins Involved in Thermal Transitions

By Shnyrov V.L.   Zhadan G.G.   Cobaleda C.   Sagrera A.   Munoz-Barroso I.   Villar E.  

Archives of Biochemistry and Biophysics, Vol. 341, Iss. 1, 1997-05 ,pp. : 89-97

Elsevier

Access to resources Recommend Favorite